PGIMS, Rohtak to go for clinical trial of Covaxin vaccine prepared by Bharat Biotech

In Haryana, Post Graduate Institute of Medical Sciences in Rohtak will go for clinical trial of Covaxin vaccine prepared by Bharat Biotech for Novel Corona virus in coordination with Indian Council of Medical Research and National Institute of Virology.

The Government of India has granted permission to 13 medical institutes in the country including PGIMS, Rohtak after successful clinical trial on animals. Giving this information, the Vice Chancellor of Health University, Rohtak Dr. O. P. Kalra said that the clinical trial will be done on 375 persons in the first phase and on 750 persons in the second phase. He said that the registration for it will start next week.

Dr Kalra said that this is first vaccine prepared in India, for which permission of clinical trial has been given. He said that Professor of Pharmacology Department Dr Savita Verma have been given the responsibility of Principal Investigator for the trial of vaccine, while State Nodal Officer for COVID-19 Dr Dhruv Chaudhary and and Dr Ramesh Verma of Community Medicine Department will be the investigator in her team.

Dr Kalra said, the trial would be done on healthy persons with no morbidity and the effect of vaccine would be observed firstly after one week and second time after 28 days. He said that the full data base of the trial would be prepared by the institute.